![Alex Fotopoulos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alex Fotopoulos
Keine laufenden Positionen mehr
Profil
Alex Fotopoulos formerly worked at Biogen, Inc., as Senior Director-Global Manufacturing Engineering from 1994 to 2011, Momenta Pharmaceuticals, Inc., as Vice President-Technical Operations from 2011 to 2016, Ultragenyx Pharmaceutical, Inc., as Senior Vice President-Technical Operations from 2017 to 2019, Dimension Therapeutics, Inc., as Senior Vice President & Head-Technical Operations from 2016 to 2017, and Passage Bio, Inc., as Chief Technical Officer from 2019 to 2023.
Mr. Fotopoulos received his graduate degree in 1997 from Tufts University and Masters Business Admin degree in 1998 from F.W.
Olin Graduate School of Business.
Ehemalige bekannte Positionen von Alex Fotopoulos
| Unternehmen | Position | Ende |
|---|---|---|
| PASSAGE BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2023 |
| ULTRAGENYX PHARMACEUTICAL INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2019 |
| DIMENSION THERAPEUTICS INC | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2017 |
| MOMENTA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2016 |
| BIOGEN INC. | Corporate Officer/Principal | 01.01.2011 |
Ausbildung von Alex Fotopoulos
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
83
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for rare diseases | Health Technology |
F.W. Olin Graduate School of Business
 F.W. Olin Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Wählen Sie MarketScreener 
